KEMRI-Wellcome
@kemriwellcome.bsky.social
20 followers 10 following 38 posts
The KEMRI Wellcome Research Programme is a world-renowned health research unit formed when the Kenya Medical Research Institute formed a partnership with the Wellcome Trust and the University of Oxford. Find out more at https://kemri-wellcome.org/
Posts Media Videos Starter Packs
kemriwellcome.bsky.social
Call for Applications📢!
Are you a PhD student or early postdoc interested in the interaction between the immune system and pathogens?
Apply for the #AFRIBOP 2026 symposium.
🗓️: March 16–20, 2026
📍: Devon Valley Hotel, Cape Town
🗓️: Deadline: October 31, 2025
Apply here 🔗: shorturl.at/Ctcd4
Reposted by KEMRI-Wellcome
tropicalmedicine.ox.ac.uk
#ResearchHighlight from Michuki Maina @kemriwellcome.bsky.social @cghr.ox.ac.uk

Applying a multi-layered, mixed methods approach to evaluate technology and workforce interventions in Kenyan neonatal units

Read more 👉 www.ndm.ac/tropmed.res-hi
Full publication 👉 www.tandfonline.com/doi/full/10....
Michuki Maina
kemriwellcome.bsky.social
🦟 Where are Kenya’s Aedes aegypti hotspots?
📚New research by @smuchiri.bsky.social et al. uses advanced modeling to predict ecological suitability, with population density emerging as the top factor, urging for the strengthening of surveillance to prevent outbreaks.
🔗: shorturl.at/TOCDB
kemriwellcome.bsky.social
The @kemriwellcome.bsky.social Vaccine Workforce Development Programme, funded by the Gates Foundation, has partnered with BioGeneric Pharma in Cairo, Egypt, with support from the Egyptian Drug Authority to deliver a 12-week programme for apprentices selected from across Africa.
kemriwellcome.bsky.social
Congratulations to Prof. Edwine Barasa on being appointed as the Executive Director of @kemriwellcome.bsky.social following the completion of a highly competitive recruitment process conducted by the Programme’s partners. @wellcometrust.bsky.social & @ox.ac.uk
Read more here : shorturl.at/QTC4a
kemriwellcome.bsky.social
Another insightful #AfHESG session covering
🔹 Real-world examples of institutionalized Health Technology Assessment processes
🔹 HTA vs. Health Benefit Package (HBP) design – similarities & differences
🔹 Integrating HTA into broader quality improvement initiatives
#HTA #HealthPolicy
kemriwellcome.bsky.social
The #AfHESG training is underway!
The session has kicked off with the Introduction to Health Technology Assessment (HTA).
Key session highlights :
🔧 Tools for explicit priority setting
📊 The role and institutionalization of HTA
🧠 Key HTA steps,skills & capacity needs
👥 Stakeholder roles in HTA
kemriwellcome.bsky.social
🚨Vaccinology Webinar alert!🚨
🌍 How can Africa build flexible, modular & nimble vaccine facilities for a sustainable future?
🗓️ October, 14th 2025
🕙 10:00 AM - 11:30 AM GMT+3
🔗 shorturl.at/jhaAA
@gatesfoundation.bsky.social
Reposted by KEMRI-Wellcome
tropicalmedicine.ox.ac.uk
New partnership aims to tackle #AntibioticOveruse in African children’s hospitals

@kemriwellcome.bsky.social is launching #PediSEP1 to fight #AMR in African children, using risk-based care to reduce unnecessary antibiotics & hospital stays

Read more 👉 www.tropicalmedicine.ox.ac.uk/news/new-par...
Healthcare worker hoding a syrindge, in front of a child patient
kemriwellcome.bsky.social
💡Want to learn how Health Technology Assessment supports better health policies and decision-making?
Join the Africa Health Economics Study Group for a hybrid training on Introduction to Health Technology Assessment.
🗓️ Date: 3rd October 2025
🔗 Register here 👉: shorturl.at/AwFpU
@lshtm.bsky.social
kemriwellcome.bsky.social
Tune in this morning to Radio Maisha and join Patrick Mbwana, Research Officer at @kemriwellcome.bsky.social, as he talks
about sickle cell and what it means for our communities during this Sickle Cell Awareness Month.
Reposted by KEMRI-Wellcome
tropicalmedicine.ox.ac.uk
#ResearchHighlight from Jay Berkley @kemriwellcome.bsky.social

Antimicrobial usage among acutely ill hospitalized children aged 2‒23 months in Sub-Saharan Africa and South Asia

Read more 👉 www.ndm.ac/tropmed.res-hi
Full publication 👉 academic.oup.com/ofid/article...
Jay Berkley
kemriwellcome.bsky.social
🩸 Every year, 400,000 children are born with Sickle Cell Disease (SCD) — most in Africa.
🇰🇪 In Kenya, 1 in 100 babies (~4,000 annually) is born with SCD.
💡Research is improving survival, with more reaching adulthood. #SickleCellAwarenessMonth
📚 Read more here : shorturl.at/86mTt
Reposted by KEMRI-Wellcome
pippa-matt.bsky.social
Shout out to @lou-downs.bsky.social & Dorcas Okanda for a prize at #COLDA. Their #HBV work in #Kenya expands insights in a neglected space, using #virus #genomics to influence healthcare.
#MedSky #NoHep
@crick.ac.uk @ndm.ox.ac.uk @ucl.ac.uk @wellcometrust.bsky.social
@kemriwellcome.bsky.social
🧪🇰🇪🌍
Photo of Dorcas and Louise with first prize certificate Photo of members of the Matthews group for hepatitis elimination at COLDA in Accra, Ghana 🇬🇭
kemriwellcome.bsky.social
The Harnessing Innovation in Global Health for Quality Care
team met with the Embu County CHMT to share study findings. As one of the study sites, the county provided an opportunity to reflect on how workforce, technology & family experiences shape the quality of newborn care.
@nihr.bsky.social
Reposted by KEMRI-Wellcome
tropicalmedicine.ox.ac.uk
#ResearchHighlight from Marta Maia, @kemriwellcome.bsky.social

Making MALDI-TOF MS for entomological parameters accessible: A practical guide for in-house library creation

Read more 👉 www.ndm.ac/tropmed.res-hi
Full publication 👉 journals.plos.org/plosone/arti...
kemriwellcome.bsky.social
🚨Vaccinology Webinar alert!🚨
💡How do Computer System Validation and Good Automated Manufacturing Practice (GAMP) shape regulatory compliance in healthcare and vaccines?
Join us for this Vaccinology webinar to learn more about this.
🗓️ September, 29th 2025
🕓 4:00 PM - 5:30 PM EAT
🔗 shorturl.at/Qju6j
kemriwellcome.bsky.social
It’s a wrap for #OTN2025! 🎉 A huge thank you to all our participants, speakers, and panelists who made this meeting a success. Your insights, energy, and collaboration have sparked meaningful conversations and strengthened connections across the network!
@wellcometrust.bsky.social @ox.ac.uk
kemriwellcome.bsky.social
For the final plenary at #OTN2025 Melissa Kapulu unpacked the journey of building a human infection study platform. From the malaria infection model to the Shigella model, she showcased a collaborative approach that blends both internal and external partnerships to refine and expand the model.
kemriwellcome.bsky.social
💡 Mid-morning #OTN2025 sessions dived into health systems, social sciences & clinical trials. These engaging talks cover critical research areas such as youth mental health illness, acute influenza clinical trials, community drivers of AMR, inpatient feeding for malnourished infants & more.
kemriwellcome.bsky.social
Day 3 of #OTN2025 featured a panel on policy engagement moderated by Fatuma Guleid. Speakers Ambrose Agweyu, Arjen Dondorp & Naomi Gibson emphasized the importance of strategic mapping, institutional support & lasting ties with policy actors to drive impact. @moru-mip.bsky.social @ox.ac.uk
kemriwellcome.bsky.social
Prof. Kevin Marsh reflected on South–North research partnerships at #OTN2025, highlighting equitable collaboration, joint graduate training, networking, sustainability & access to resources as key foundations for impactful global research.
@wellcometrust.bsky.social @ox.ac.uk @moru-mip.bsky.social
kemriwellcome.bsky.social
Day 2 Talks at #OTN2025 explored motivations for childhood vaccination in trials, building social science around controlled human infection studies, the impact of M. tuberculosis lineage, and blood-based signatures to improve TB meningitis diagnosis.
@moru-mip.bsky.social @oucru.bsky.social
kemriwellcome.bsky.social
Rich conversations during the #OT2025 panel discussion
on understanding climate change - including the use of technology AI & innovation in climate change, collaborations to improve research and the role of young people voices in climate change innovation, decisions & implementation.
@ox.ac.uk